Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/53452
Title: Selenium-capped cyclic peptide nanoparticles for penicillamine drug delivery: A DFT Study
Authors: Moghimi, Sara
Morsali, Ali
Heravi, Mohammad M
Keywords: Selenium nanoparticle;Cyclic peptide;Penicillamine;Drug delivery;Density Functional Theory (DFT)
Issue Date: Jan-2020
Publisher: NISCAIR-CSIR, India
Abstract: Using a model for performance of penicillamine (PCA) anti-cancer drug on selenium-cyclic peptide nanoparticle (CPSeNP), 11 noncovalent configurations have been investigated. Se8 ring model and cyclooctaglycine have been used for selenium nanoparticle (SeNP) and cyclic peptide (CP), respectively. Binding energies, quantum molecular descriptors and solvation energies have been studied in gas phase and water at M06-2X /6-31G** level of theory. The calculated energies represent the high-energy stability of CPSeNP/PCA 1-11 configurations. Solvation energies showed that drug solubility increases, which is a major factor for their use in drug delivery. Regarding to quantum molecular descriptors such as hardness and electrophilic power, the drug reactivity increases in the vicinity of SeNP. The QTAIM analysis revealed that intramolecular interaction Se-L (L =O, H , S, C , N) plays an important role in the system. Se-L interaction in all configurations is relevant to weak interactions. The configurations that PCA drug is located in parallel with the carrier (CPSeNP) are more stable than penicillamine-CP or penicillamine-SeNP systems.
Page(s): 43-50
URI: http://nopr.niscair.res.in/handle/123456789/53452
ISSN: 0975-0975(Online); 0376-4710(Print)
Appears in Collections:IJC-A Vol.59A(01) [January 2020]

Files in This Item:
File Description SizeFormat 
IJCA 59A(1) 43-50.pdfMain Article456.4 kBAdobe PDFView/Open
IJCA 59A(1) 43-50_Suppl Data.pdfSupplementary Data193.09 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.